Floatz logo

SIMVASTATIN

Dementia, Vascular

Jaime Daniel MondragonSmall moleculePhase 2/3Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Dementia, Vascular cohort.

Asset / SponsorPhaseRating
Risperdal
Janssen-Cilag Pty Ltd
Phase 3BB
OXYCODONE HYDROCHLORIDE, HYDROCODONE-
VA Office of Research and Development
Phase 4BB
Lipitor
Monash University
Phase 4BB
PERPHENAZINE
Bruce Pollock
Phase 3BB
CITALOPRAM
Bruce Pollock
Phase 3BB

View all 18 →

Same molecule, other indications

SIMVASTATIN is also rated in:

HypercholesterolemiaDormant
BBB
Indicative ·
76 / 100
View asset →
psychotic disorderDormant
BBB
Indicative ·
75 / 100
View asset →
inherited lipid metabolism disorderDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →